REG - Agronomics Limited - Agronomics Welcomes Marisa Drew as a Director

AgronomicsAnnouncement

23/02/2023 07:01

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230223:nRSW6296Qa&default-theme=true

RNS Number : 6296Q  Agronomics Limited  23 February 2023

23 February 2023

 

Agronomics Limited (https://agronomics.im/)

 

("Agronomics" or the "Company")

 

Agronomics Welcomes Marisa Drew to the Board of Directors

Agronomics (ANIC:LSE), the leading listed company focused on the field of
cellular agriculture is pleased to announce that it has today appointed Marisa
Drew as an Independent Non-Executive Director. Marisa Drew is the inaugural
Chief Sustainability Officer ("CSO") of Standard Chartered Bank Plc,
responsible for setting the bank's sustainability strategy and the delivery of
the firm's commitment to net zero carbon emissions by 2050 as well as
overseeing the sustainable finance client-facing activities of the bank. Prior
to this, she held the CSO role at Credit Suisse as well as being CEO of the
Sustainability Strategy, Advisory & Finance Group. Marisa also Co-Chaired
the Sustainability Leaders Committee, served on the ESG Steering Committee,
the Climate Risk Strategy Steering Committee, and the UK Reputational Risk
Committee of the bank. Marisa also sits on the member of the UK Financial
Conduct Authority's Markets Practitioner Panel and has served on several High
Level Working Groups ("HLG") sponsored by the World Economic Forum and the UN,
including as co-chair of the HLG for Humanitarian Aid and the Oceans Panel.

As a globally recognised leader in sustainability, Marisa brings a vast wealth
of experience to the Board and is thoroughly aligned with Agronomics' mission
of bringing sustainable alternatives to agricultural products to consumers by
investing in leading cellular agriculture companies.

Marisa Drew, Non-Executive Director of Agronomics commented: -

"I am delighted to be joining the Board of Agronomics at this truly exciting
time in the field of cellular agriculture. Over the past year, Agronomics has
grown its portfolio and is investing in ground-breaking companies and
technologies creating a more sustainable protein production system. I look
forward to working with my fellow board members to support the growth of the
portfolio companies and scaling of the industry."

Jim Mellon, Co-Founder and Executive Director of Agronomics commented: -

"It is a pleasure to welcome Marisa to Agronomics' Board of Directors. Marisa
brings with her a wealth of experience, particularly in the sphere of
sustainability, and has a track record of achieving investor returns in her
previous roles. As a recognised leader in sustainability, Marisa will be well
equipped to work with Agronomics' senior team to enhance its portfolio and
help advance the prospects for the field of cellular agriculture."

Marisa Danielle Drew (aged 58) is or has during the last five years been a
director or partner of the following companies and partnerships:

 Current:                        Past:
 Liberty Global PLC              Sunrise Communications Group AG
 Cash & Rocket Holdings Ltd
 Aspen Institute UK

 

Marisa Drew is also on the Advisory Boards of the Financial Conduct Authority
(Expert Markets Practitioners Advisory Panel), The City of London Corporation
and Room to Read, an education charity, and was on the Advisory Board at The
Wharton School (EMEA Countries Advisory Board) until 2022.

 

Other than as disclosed above, there are no further disclosures to be made in
accordance with AIM Rule 17 and paragraph (g) of Schedule Two of the AIM Rules
for Companies.

About Agronomics (https://agronomics.im/)

Agronomics is a leading listed alternative proteins company with a focus on
cellular agriculture and cultivated meat. The Company has established a
portfolio of over 20 companies in this rapidly advancing sector. It seeks to
secure minority stakes in companies owning technologies with defensible
intellectual property that offer new ways of producing food and materials with
a focus on products historically derived from animals. These technologies are
driving a major disruption in agriculture, offering solutions to improve
sustainability, as well as addressing human health, animal welfare and
environmental damage. This disruption will decouple supply chains from the
environment and animals, as well as being fundamental to feeding the world's
expanding population. A full list of Agronomics' portfolio companies is
available at https://agronomics.im/
(https://clicktime.symantec.com/368cVqxx3R6vTFuHpf6MSE66Gi?u=https%3A%2F%2Fagronomics.im%2F)
.

 

About Cellular Agriculture

Cellular Agriculture is the production of agriculture products directly from
cells, as opposed to raising an animal for slaughter, or growing crops. This
encompasses cell culture to produce cultivated meat and materials, and
fermentation processes that harness a combination of molecular biology,
synthetic biology, tissue engineering and biotechnology to massively simplify
production methods in a sustainable manner.

 

Over the coming decades, the source of the world's food supply traditionally
derived from conventional agriculture is going to change dramatically. We have
already witnessed the first wave of this shift with the consumer adoption of
plant-based alternative proteins but today, we are on the cusp of an even
bigger wave of change. This is being facilitated by advances in cellular
agriculture. This change is necessary, given scientists claims that if we
maintain existing animal protein consumption patterns, then we will not meet
the Paris Agreement's goal of limiting warming to 1.5℃.

 

AT Kearney, a global consultancy firm, projects that cultivated meat's market
share will reach 35% by 2040. This combined with the Good Food Institute's
estimate that a US $1.8 trillion investment will be required in order to
produce just 10% of the world's protein using this technology, means that we
are on the cusp of a multi-decade flow of capital to build out manufacturing
facilities. Funding in the field of cellular agriculture is accelerating,
however still less than US$ 5 billion has been invested worldwide since the
industry's inception in 2016.

 

This announcement contains inside information for the purposes of Article 7 of
the Market Abuse Regulation (EU) No. 596/2014, as it forms part
of UK Domestic Law by virtue of the European Union (Withdrawal) Act 2018.
Upon the publication of this announcement, this inside information is now
considered to be in the public domain.

 

For further information please contact:

 

 Agronomics                                       Beaumont              Canaccord              Cenkos                Peterhouse Capital

 Limited                                          Cornish Limited       Genuity Limited        Securities Plc        Limited               TB Cardew
 The Company                                      Nomad                 Joint Broker           Joint Broker          Joint Broker          Public Relations
 Richard Reed                                     Roland Cornish        Andrew Potts           Giles Balleny         Lucy Williams          Ed Orlebar

 Denham Eke                                       James Biddle          Harry Rees             Max Gould             Charles Goodfellow    Alistair Walker

                                                                        Alex Aylen             Michael Johnson

                                                                        (Head of Equities)
 +44 (0) 1624 639396                              +44 (0) 207 628 3396                         +44 (0) 207 397 8900  +44 (0) 207 469 0936  +44 (0) 20 7930 0777

 info@agronomics.im (mailto:info@agronomics.im)                         +44 (0) 207 523 8000                                               +44 (0) 7738 724 630

                                                                                                                                           agronomics@tbcardew.com (mailto:agronomics@tbcardew.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCSEWFUFEDSEDE